Cannara Biotech Inc.
LOVFF
Rank in Stocks
#18161
Cannara Biotech Inc., alongside its affiliated entities, specializes in the... Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing both cannabis operations and real estate activities. Its diverse product portfolio is marketed under distinct brand names such as TRIBAL, nugz, and ORCHID CBD. Distribution is managed through both wholesale channels and online retail platforms. Established in 2017, Cannara Biotech Inc. maintains its headquarters in Saint-Laurent, Canada.
Share Price
$1.49
Last synced: 2026-11-09
Market Cap
$142.70M
Change (1 day)
-1.71%
Change (1 year)
26.61%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cannara Biotech Inc. (LOVFF)
Category
Healthcare
EPS for Cannara Biotech Inc. (LOVFF)
EPS as of May 2026 TTM: $0.09
According to Cannara Biotech Inc.'s latest financial reports, its current EPS (TTM) is $0.09. At the end of 2025 the company had an EPS of $0.10, an increase over its 2024 EPS of $0.05.
EPS history for Cannara Biotech Inc. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.09 | -14.20% |
| 2025 | $0.10 | 95.59% |
| 2024 | $0.05 | -9.55% |
| 2023 | $0.06 | 188.00% |
| 2022 | $0.02 | -225.79% |
| 2021 | $-0.02 | -87.81% |
| 2020 | $-0.13 | 2.52% |
| 2019 | $-0.13 | 443.59% |
| 2018 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 7,477.39% |
DE
|
|
| $6.08 | 6,983.45% |
DE
|
|
| $1.55 | 1,707.23% |
JP
|
|
| $3.66 | 4,165.73% |
CH
|
|
| $0.45 | 424.48% |
IL
|
Questions about Cannara Biotech Inc.'s earnings per share (EPS)
What is Cannara Biotech Inc.'s earnings per share (EPS)?
Cannara Biotech Inc.'s earnings per share (EPS) over the last twelve months is $0.09, as of May 2026.
What was Cannara Biotech Inc.'s earnings per share (EPS) in 2025?
In 2025, Cannara Biotech Inc.'s earnings per share (EPS) was $0.10, 100.00% more than in 2024 ($0.05).
How has Cannara Biotech Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Cannara Biotech Inc.'s earnings per share (EPS) was highest in 2025 ($0.10) and lowest in 2020 ($-0.13).
How does Cannara Biotech Inc.'s earnings per share (EPS) compare with similar companies?
Cannara Biotech Inc.'s earnings per share (EPS) ($0.09) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.